The parkinsonian neurotoxin rotenone activates calpain and caspase-3 leading to motoneuron degeneration in spinal cord of Lewis rats.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Neuroscience

• Publication date

  2007-05-11

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1016/J.NEUROSCIENCE.2007.01.056PMID 17367952PMCID PMC1940329
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chemokines in the MPTP model of Parkinson's disease: absence of CCL2 and its receptor CCR2 does not protect against striatal neurodegeneration.

  2007cited by this paper
• A rat model of Parkinsonism shows depletion of dopamine in the retina.

  2007cited by this paper
• Natural history of Parkinson's disease: From dopamine to multiple system involvement

  2006influential reference
• α‐Synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects

  2006cited by this paper
• Neurodegeneration induced by complex I inhibition in a cellular model of familial amyotrophic lateral sclerosis.

  2006cited by this paper
• A delivery strategy for rotenone microspheres in an animal model of Parkinson's disease.

  2006cited by this paper
• Progressive Dopamine Neuron Loss in Parkinson's Disease: The Multiple Hit Hypothesis

  2006cited by this paper
• Behavioral models of Parkinson's disease in rodents: A new look at an old problem

  2006cited by this paper
• Estrogen prevents glutamate-induced apoptosis in C6 glioma cells by a receptor-mediated mechanism.

  2006cited by this paper
• Activation of multiple molecular mechanisms for apoptosis in human malignant glioblastoma T98G and U87MG cells treated with sulforaphane.

  2006cited by this paper
• Parkinson's Disease α-Synuclein Transgenic Mice Develop Neuronal Mitochondrial Degeneration and Cell Death

  2006cited by this paper
• Calpain Activation in Apoptosis of Motoneurons in Cell Culture Models of Experimental Parkinsonism

  2006cited by this paper
• Enhanced sensitivity of dopaminergic neurons to rotenone-induced toxicity with aging.

  2006cited by this paper
• Alpha-synuclein pathology in the spinal cords of neurologically asymptomatic aged individuals.

  2006cited by this paper
• Neurodegeneration Produced by Rotenone in the Mouse Retina: A Potential Model to Investigate Environmental Pesticide Contributions to Neurodegenerative Diseases

  2006cited by this paper
• Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death.

  2006cited by this paper
• Early induction of calpains in rotenone-mediated neuronal apoptosis.

  2006cited by this paper
• Rotenone induces aggregation of γ-tubulin protein and subsequent disorganization of the centrosome: Relevance to formation of inclusion bodies and neurodegeneration

  2005cited by this paper
• Caspase and calpain function in cell death: bridging the gap between apoptosis and necrosis

  2005cited by this paper
• Selective Vulnerability of Dopaminergic Neurons to Microtubule Depolymerization*

  2005cited by this paper
• Alpha‐synuclein immunohistochemistry in two cases of co‐occurring idiopathic Parkinson's disease and motor neuron disease

  2005cited by this paper
• Microglial activation and dopamine terminal loss in early Parkinson's disease

  2005influential reference
• Low levels of ALS-linked Cu/Zn superoxide dismutase increase the production of reactive oxygen species and cause mitochondrial damage and death in motor neuron-like cells.

  2005cited by this paper
• Immunofluorescent labeling of increased calpain expression and neuronal death in the spinal cord of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice.

  2004cited by this paper
• Inflammation and neurodegeneration in Parkinson's disease.

  2004cited by this paper
• Effects of mitochondrial dysfunction on glutamate receptor-mediated neurotoxicity in cultured rat spinal motor neurons.

  2004cited by this paper
• Parkinsonism in motor neuron disease: case report and literature review

  2004cited by this paper
• Neurotoxicant-induced animal models of Parkinson’s disease: understanding the role of rotenone, maneb and paraquat in neurodegeneration

  2004cited by this paper
• Inhibition of proteasome activity sensitizes dopamine neurons to protein alterations and oxidative stress

  2004cited by this paper
• Interplay between mitochondria and cellular calcium signalling

  2004cited by this paper
• The Role of Glial Reaction and Inflammation in Parkinson's Disease

  2003influential reference
• Calpain and its involvement in the pathophysiology of CNS injuries and diseases: therapeutic potential of calpain inhibitors for prevention of neurodegeneration.

  2003cited by this paper
• Mitochondrial Complex I Inhibitor Rotenone Induces Apoptosis through Enhancing Mitochondrial Reactive Oxygen Species Production*

  2003cited by this paper
• Mitochondrial Mechanisms of Neural Cell Death and Neuroprotective Interventions in Parkinson's Disease

  2003cited by this paper
• Ca2+‐induced oxidative stress in brain mitochondria treated with the respiratory chain inhibitor rotenone

  2003cited by this paper
• Parkinson's Disease Mechanisms and Models

  2003cited by this paper
• Mechanism of Toxicity in Rotenone Models of Parkinson's Disease

  2003influential reference
• Inhibition of Calpains Prevents Neuronal and Behavioral Deficits in an MPTP Mouse Model of Parkinson's Disease

  2003cited by this paper
• Mechanism for generation of hydrogen peroxide and change of mitochondrial membrane potential during rotenone-induced apoptosis.

  2003influential reference
• Staging of brain pathology related to sporadic Parkinson's disease.

  2003cited by this paper
• The pesticide rotenone induces caspase‐3‐mediated apoptosis in ventral mesencephalic dopaminergic neurons

  2003cited by this paper
• Mitochondria, Oxidative Damage, and Inflammation in Parkinson's Disease

  2003cited by this paper
• An In Vitro Model of Parkinson's Disease: Linking Mitochondrial Impairment to Altered α-Synuclein Metabolism and Oxidative Damage

  2002influential reference
• Distinct Role for Microglia in Rotenone-Induced Degeneration of Dopaminergic Neurons

  2002cited by this paper
• Synergistic effects of pesticides and metals on the fibrillation of alpha-synuclein: implications for Parkinson's disease.

  2002influential reference
• Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages)

  2002cited by this paper
• Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats.

  2002influential reference
• Calpain Upregulation and Neuron Death in Spinal Cord of MPTP‐Induced Parkinsonism in Mice

  2002cited by this paper
• Mitochondria, Ca2+ and neurodegenerative disease.

  2002cited by this paper
• Early sequential formation of functional GABAA and glutamatergic synapses on CA1 interneurons of the rat foetal hippocampus

  2002cited by this paper
• Alpha-synuclein and neurodegenerative diseases

  2001cited by this paper
• Capsaicin-induced depolarisation of mitochondria in dorsal root ganglion neurons is enhanced by vanilloid receptors.

  2001cited by this paper
• α-Synuclein immunopositive Parkinson's disease-related inclusion bodies in lower brain stem nuclei

  2001cited by this paper
• Transgenic ALS mice show increased vulnerability to the mitochondrial toxins MPTP and 3-nitropropionic acid.

  2001cited by this paper
• A meta-analysis of Parkinson's disease and exposure to pesticides.

  2000cited by this paper
• Chronic systemic pesticide exposure reproduces features of Parkinson's disease

  2000influential reference
• Calpain Upregulation in Spinal Cords of Mice with 1‐Methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐induced Parkinson's Disease

  2000cited by this paper
• Combined TUNEL and double immunofluorescent labeling for detection of apoptotic mononuclear phagocytes in autoimmune demyelinating disease.

  2000cited by this paper
• In Vivo Labeling of Mitochondrial Complex I (NADH:UbiquinoneOxidoreductase) in Rat Brain Using [3H]Dihydrorotenone

  2000cited by this paper
• The inflammatory reaction following 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine intoxication in mouse.

  1999cited by this paper
• Inosine and guanosine preserve neuronal and glial cell viability in mouse spinal cord cultures during chemical hypoxia.

  1999cited by this paper
• Mitochondrial dysfunction in Parkinson's disease.

  1999cited by this paper
• Caspases: the proteases of the apoptotic pathway

  1998cited by this paper
• The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living

  1998cited by this paper
• Inhibitors of NADH-ubiquinone reductase: an overview.

  1998cited by this paper
• Midbrain dopaminergic neuronal degeneration in a transgenic mouse model of familial amyotrophic lateral sclerosis

  1997cited by this paper
• Alpha-synuclein in Lewy bodies.

  1997cited by this paper
• The intermediolateral nucleus and Clarke’s column in Parkinson’s disease

  1997cited by this paper
• Increased M-calpain expression in the mesencephalon of patients with Parkinson's disease but not in other neurodegenerative disorders involving the mesencephalon: a role in nerve cell death?

  1996cited by this paper
• The localization of mcalpain in myelin: immunocytochemical evidence in different areas of rat brain and nerves.

  1995cited by this paper
• Pathophysiology of parkinsonian motor abnormalities.

  1993cited by this paper
• Diminution of dopaminergic neurons in the substantia nigra of sporadic amyotrophic lateral sclerosis

  1993cited by this paper
• Degeneration of the substantia nigra in familial amyotrophic lateral sclerosis.

  1991cited by this paper
• Mitochondrial complex I deficiency in Parkinson's disease.

  1989cited by this paper
• Mitochondrial Complex I Deficiency in Parkinson's Disease

  1989cited by this paper
• Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease.

  1989cited by this paper
• Purification of a calcium-activated neutral proteinase from bovine brain

  1983cited by this paper
• Medicine and the Law

  1983cited by this paper

• Epigallocatechin-3-Gallate, Quercetin, and Kaempferol for Treatment of Parkinson’s Disease Through Prevention of Gut Dysbiosis and Attenuation of Multiple Molecular Mechanisms of Pathogenesis

  2025cites this paper
• Neuroprotective Effects of Calpain Inhibition in Parkinson’s Disease: Insights from Cellular and Murine Models

  2025cites this paper
• The potential ameliorative effect of mesenchymal stem cells-derived exosomes on cerebellar histopathology and their modifying role on PI3k-mTOR signaling in rat model of autism spectrum disorder

  2025cites this paper
• The Ca^2+-Regulated Enzymes Calpain and Calcineurin in Neurodegenerative Processes and Prospects for Neuroprotective Pharmacotherapy

  2024cites this paper
• Spiral volumetric optoacoustic tomography of reduced oxygen saturation in the spinal cord of M83 mouse model of Parkinson’s disease

  2024cites this paper
• TUNEL-n-DIFL Method for Detection and Estimation of Apoptosis Specifically in Neurons and Glial Cells in Mixed Culture and Animal Models of Central Nervous System Diseases and Injuries.

  2024cites this paper
• Rosinidin inhibits NF-κB/ Nrf2/caspase-3 expression and restores neurotransmitter levels in rotenone-activated Parkinson's disease

  2023cites this paper
• [Ca2+-regulated enzymes calpain and calcineurin in neurodegenerative processes and prospects for neuroprotective pharmacotherapy].

  2023cites this paper
• Evaluation of hazards of electronic -cigarette’s liquid refill on testes of mice, complemented by histopathological and chromatographic analysis

  2023cites this paper
• Calpain Mediated Neurodegeneration in Parkinson’s disease

  2023cites this paper
• TNK2/ACK1-mediated phosphorylation of ATP5F1A (ATP synthase F1 subunit alpha) selectively augments survival of prostate cancer while engendering mitochondrial vulnerability

  2022cites this paper
• Inhibition of Calpain Attenuates Degeneration of Substantia Nigra Neurons in the Rotenone Rat Model of Parkinson’s Disease

  2022cites this paper
• Recuperative effect of estrogen on rotenone-induced experimental model of Parkinson’s disease in rats

  2021influential citation
• Cellular and molecular pathophysiology in the progression of Parkinson’s disease

  2021cites this paper
• Platinum nanoparticles Protect Against Lipopolysaccharide-Induced Inflammation in Microglial BV-2 Cells via Decreased Oxidative Damage and Increased Phagocytosis

  2021cites this paper
• Chronic MPTP in Mice Damage-specific Neuronal Phenotypes within Dorsal Laminae of the Spinal Cord

  2020cites this paper
• Parkin interacts with Mitofilin to increase dopaminergic neuron death in response to Parkinson's disease-related stressors.

  2020cites this paper
• Neuroprotective Role of Quercetin on Rotenone-Induced Toxicity in SH-SY5Y Cell Line Through Modulation of Apoptotic and Autophagic Pathways

  2020cites this paper
• Bee venom attenuates neurodegeneration and motor impairment and modulates the response to L-dopa or rasagiline in a mice model of Parkinson’s disease

  2020cites this paper
• Rotenone neurotoxicity: Relevance to Parkinson's disease

  2020cites this paper
• Calpain mediated expansion of CD4+ cytotoxic T cells in rodent models of Parkinson's disease.

  2020cites this paper
• The migration of multipotent mesenchymal stromal cells after systemic and local administration in an experimental model of Parkinson’s disease

  2019cites this paper
• Synthesis, characterization and efficacy of mitochondrial targeted delivery of TPP-curcumin in rotenone-induced toxicity

  2019cites this paper
• Motor Neurons Pathology After Chronic Exposure to MPTP in Mice

  2019cites this paper
• Demethoxycurcumin ameliorates rotenone-induced toxicity in rats.

  2019cites this paper
• Should we reconsider the apoptosis as a strategic player in tissue regeneration?

  2019cites this paper
• Effect of Chlorogenic Acid Supplementation in MPTP-Intoxicated Mouse

  2018cites this paper
• Melatonin, a calpain inhibitor in the central nervous system: Current status and future perspectives

  2018cites this paper
• Identification of FDA-approved drugs as novel allosteric inhibitors of human executioner caspases

  2018cites this paper
• Parkinson's disease research: adopting a more human perspective to accelerate advances.

  2018cites this paper
• Neuroprotective Effects of Filgrastim in Rotenone-Induced Parkinson’s Disease in Rats: Insights into its Anti-Inflammatory, Neurotrophic, and Antiapoptotic Effects

  2018cites this paper
• Neuroprotective Effect of Agaricus Blazei Extract Against Rotenone-Induced Motor and Nonmotor Symptoms in Experimental Model of Parkinson’s Disease

  2018cites this paper
• The role of calpain in spinal cord degeneration in experimental Pаrkinson’s disease

  2018cites this paper
• Mild Exercise Differently Affects Proteostasis and Oxidative Stress on Motor Areas During Neurodegeneration: A Comparative Study of Three Treadmill Running Protocols

  2018cites this paper
• Growth Factors and Neuroglobin in Astrocyte Protection Against Neurodegeneration and Oxidative Stress

  2018cites this paper
• Functional analysis of the parkinsonism-associated protein FBXO7 (PARK15) in neurons

  2017cites this paper
• Differential expression of human g -tubulin isotypes during neuronal development and oxidative stress points to a g -tubulin-2 prosurvival function Differential expression of human g isotypes during neuronal devel-opmentandoxidativestresspointsto g -tubulin-2prosurvivalfunction.FASEBJ.31,1828

  2017cites this paper
• Differential expression of human γ‐tubulin isotypes during neuronal development and oxidative stress points to a γ‐tubulin‐2 prosurvival function

  2017cites this paper
• Inflammation: the Common Link in Brain Pathologies

  2016cites this paper
• Administration of low dose estrogen attenuates gliosis and protects neurons in acute spinal cord injury in rats

  2016influential citation
• Regulation des Ubiquitin-Proteasom-Systems unter proteotoxischem Stress

  2016cites this paper
• Neuroinflammation During Parkinson’s Disease: Key Cells and Molecules Involved in It

  2016cites this paper
• Bee Venom Protects against Rotenone-Induced Cell Death in NSC34 Motor Neuron Cells

  2015cites this paper
• Long-Term Systemic Exposure to Rotenone Induces Central and Peripheral Pathology of Parkinson’s Disease in Mice

  2015cites this paper
• Chronic intermittent ethanol induced axon and myelin degeneration is attenuated by calpain inhibition.

  2015cites this paper
• The Rotenone Model of Parkinson's Disease in Studying the Mechanisms of Nigrostriatal Cell Death

  2015cites this paper
• Autofagocitose e estresse oxidativo no sistema nervoso central de ratos idosos submetidos ao exercício físico moderado

  2015cites this paper
• Endoplasmic Reticulum Stress Instigates the Rotenone Induced Oxidative Apoptotic Neuronal Death: a Study in Rat Brain

  2015cites this paper
• Inhibition of Apoptosis and Efficacy of Pan Caspase Inhibitor, Q-VD-OPh, in Models of Human Disease

  2015cites this paper
• Inhibition of Calpain Activation Protects MPTP-Induced Nigral and Spinal Cord Neurodegeneration, Reduces Inflammation, and Improves Gait Dynamics in Mice

  2015cites this paper
• Astrocytic modulation of blood brain barrier: perspectives on Parkinson’s disease

  2014cites this paper
• Neuroprotective Effects of Metallothionein Against Rotenone-Induced Myenteric Neurodegeneration in Parkinsonian Mice

  2014cites this paper
• SNJ‐1945, a calpain inhibitor, protects SH‐SY5Y cells against MPP+ and rotenone

  2014cites this paper
• EFFECT OF HYDRO-ALCOHOLIC ROOT EXTRACT OF PLUMBAGO ZEYLANICA L ALONE AND IT’S COMBINATION WITH AQUEOUS LEAF EXTRACT CAMELLIA SINENSIS ON ROTENONE INDUCED PARKINSONISM

  2014cites this paper
• MPTP Neurotoxicity: Actions, Mechanisms, and Animal Modelling of Parkinson’s Disease

  2014cites this paper
• Melatonin’s Protection against Methamphetamine Toxicity in Neuroblastoma Cells

  2014cites this paper
• The Impact of Recombinant Human Erythropoietin Treatment on Motor Impairment in Rotenone-Induced Parkinsonism in Rats

  2014cites this paper
• The synchronous and reciprocal regulation of the activities of cysteine proteases associated with long-term plasticity

  2013cites this paper
• Rotenone-induced neurotoxicity in rat brain areas: a study on neuronal and neuronal supportive cells.

  2013cites this paper
• Effect of copper overload on the survival of HepG2 and A-549 human-derived cells

  2013cites this paper
• Critical role of calpain in spinal cord degeneration in Parkinson's disease

  2013influential citation
• Astrocytes Role in Parkinson: A Double-Edged Sword

  2013cites this paper
• The neurobiology of the spinal cord in experimental parkinsonism and Parkinson's disease.

  2013cites this paper
• Angiopep-Conjugated Nanoparticles for Targeted Long-Term Gene Therapy of Parkinson’s Disease

  2013cites this paper
• Betaine Protects Against Rotenone-Induced Neurotoxicity in PC12 Cells

  2013cites this paper
• Astrocyte Activation: A Key Step in Rotenone Induced Cytotoxicity and DNA Damage

  2012cites this paper
• Acetyl-L-carnitine and α-lipoic acid affect rotenone-induced damage in nigral dopaminergic neurons of rat brain, implication for Parkinson's disease therapy.

  2012cites this paper
• Mitochondrial functions in astrocytes: neuroprotective implications from oxidative damage by rotenone.

  2012cites this paper
• Transcriptome Analysis of a Rotenone Model of Parkinsonism Reveals Complex I-Tied and -Untied Toxicity Mechanisms Common to Neurodegenerative Diseases

  2012cites this paper
• The oxidative damage and inflammation caused by pesticides are reverted by lipoic acid in rat brain.

  2012cites this paper
• Loss of spinal motor neurons and alteration of alpha-synuclein immunostaining in MPTP induced Parkinsonism in mice.

  2012cites this paper
• Role of Apoptosis in disease

  2012cites this paper
• Effect of Cynodon dactylon on rotenone induced Parkinson’s disease

  2012cites this paper
• Controlled release of rasagiline mesylate promotes neuroprotection in a rotenone-induced advanced model of Parkinson's disease.

  2012cites this paper
• Cytotoxic effects of copper overload on human-derived lung and liver cells in culture.

  2012cites this paper
• Study of the etiology of neurolathyrism, a human neurodegenerative disease with nutritional causes

  2011cites this paper
• Calpain inhibition protected spinal cord motoneurons against 1-methyl-4-phenylpyridinium ion and rotenone.

  2011cites this paper
• Spinal cord and parkinsonism: neuromorphological evidences in humans and experimental studies.

  2011cites this paper
• Tracking extranigral degeneration in animal models of Parkinson’s disease: quest for effective therapeutic strategies

  2011influential citation
• Mitochondrial Dysfunction: The Road to Alpha-Synuclein Oligomerization in PD

  2011cites this paper
• Postinjury estrogen treatment of chronic spinal cord injury improves locomotor function in rats

  2010cites this paper
• Gene therapy using lactoferrin-modified nanoparticles in a rotenone-induced chronic Parkinson model.

  2010cites this paper
• The protective effect of melatonin on methamphetamine‐induced calpain‐dependent death pathway in human neuroblastoma SH‐SY5Y cultured cells

  2010cites this paper
• Effect of pesticides on cell survival in liver and brain rat tissues.

  2009influential citation
• Calpain-mediated MPP+ toxicity in mitochondrial DNA depleted cells

  2009cites this paper
• EFECTO DE CONTAMINANTES AMBIENTALES SOBRE EL METABOLISMO LIPÍDICO Y EL SISTEMA DE DEFENSA ANTIOXIDANTE EN TEJIDOS DE RATA

  2009cites this paper
• ICP10PK inhibits calpain-dependent release of apoptosis-inducing factor and programmed cell death in response to the toxin MPP+

  2008cites this paper
• Calpain-Mediated Signaling Mechanisms in Neuronal Injury and Neurodegeneration

  2008cites this paper
• Behavioral alterations in rotenone model of Parkinson's disease: attenuation by co-treatment of centrophenoxine.

  2008cites this paper
• Calpain as a potential therapeutic target in Parkinson's disease.

  2008cites this paper
• Pathways of Methamphetamine Toxicity

  2008cites this paper
• Extranigral Neurodegeneration in Parkinson's Disease

  2008cites this paper
• Spinal cord degeneration in C57BL/6N mice following induction of experimental parkinsonism with MPTP

  2008cites this paper
• Inhibitory Effect of PACAP on Caspase Activity in Neuronal Apoptosis: A Better Understanding Towards Therapeutic Applications in Neurodegenerative Diseases

  2008cites this paper
• Melatonin attenuates calpain upregulation, axonal damage and neuronal death in spinal cord injury in rats

  2008cites this paper
• Literature-Related Discovery (LRD)

  2007cites this paper
• Is Parkinson's disease an autoimmune disorder of endogenous vasoactive neuropeptides?

  2007cites this paper